ALFA Filings
Every announcement, straight from the exchange
Every Vaishali Pharma board meeting outcome announcement on NSE and BSE, newest first, each with its own page.
Time
2 announcements
Vaishali Pharma's Board approved increasing authorized share capital from ₹27 Cr to ₹29 Cr. The proposal requires member approval and MoA amendments.
Vaishali Pharma approved the five-year re-appointment of its Independent, Managing, and Whole-Time Directors. These leadership extensions ensure management continuity and strategic stability for shareholders.